retatrutide discord Significantly Reduces Visceral Fat in Clinical Trials Scrutiny of WNBA intensifies as

Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial

Retatrutides side effects look a lot like those of other GLP-1-based medications, and most are related to digestion

Ozempics SELECT trial showed that patients taking semaglutide had a 20% lower risk of heart attack, stroke, or cardiovascular death compared to placebo

You should not use GLP-1 medications if you have: Personal or family history of medullary thyroid cancer Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Previous severe allergic reaction to semaglutide or liraglutide Current pregnancy or planning to become pregnant History of pancreatitis (requires careful evaluation) Severe gastrointestinal disease Additionally, these medications are not typically recommended for patients under 18 years old, though Saxenda has some pediatric approval for adolescents 12 and older with obesity